Intralesional purified protein derivative of tuberculin versus intralesional mycobacterium W vaccine in treatment of recalcitrant extragenital warts: A randomized, single-blinded, comparative study
Introduction: Of late, immunotherapy has emerged as a promising therapeutic modality for the treatment of recalcitrant and difficult to treat warts. Purified protein derivative of tuberculin (PDD) and mycobacterium w (Mw) vaccine hold promising prospects for the treatment of verruca, especially in a...
Saved in:
Main Authors: | Alpana Mohta (Author), Suresh Kumar Jain (Author), Rajesh Dutt Mehta (Author), Aakanksha Arora (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the efficacy and safety of the intralesional purified protein derivative of tuberculin versus intralesional vitamin D3 for the management of recalcitrant warts
by: Manoj Kumar Sharma, et al.
Published: (2023) -
A novel intralesional treatment with Aureobasidium for recalcitrant warts
by: Neha Arora, MBA, et al.
Published: (2023) -
Evaluation of the efficacy of intralesional measles, mumps, and rubella vaccine with intralesional Vitamin D3 as immunotherapies in the treatment of recalcitrant cutaneous warts in adult- A randomized placebo-controlled study
by: Alpana Mohta, et al.
Published: (2021) -
Intralesional cidofovir for the treatment of recalcitrant periungual warts
by: McKayla Poppens, et al.
Published: (2023) -
An intention-to-treat-analysis of the efficacy of immunotherapy using Mycobacterium w vaccine and Purified Protein Derivative of Tuberculin for warts with assessment of improvement in quality of life
by: Alpana Mohta, et al.
Published: (2022)